REGULATIONS Archives

China's Medtech Volume-Based Procurement Big Savings, Bigger Challenges by EOS Implicium

China VBP: Turning Down the Volume on MedTech Margins

22/10/2025by EOS Intelligence

China’s phased rollout of Volume-Based Procurement (VBP), which started in the pharmaceutical industry in 2018, quickly expanded to the medical devices market in 2019. VBP standardizes medical device prices in...

Recall Fallout Lets Rivals Gain Ground in Sleep Apnea and Ventilators

13/08/2025by EOS Intelligence

In recent years, the number of ventilator recalls has increased considerably, primarily due to product quality issues, software malfunctions, and manufacturing defects. This affected manufacturers such as Philips, Medtronic, and...

Cashless Sweden Runs Ahead, but Resilience May Be the Real Test

14/04/2025by EOS Intelligence

Sweden’s cashless initiative is gaining momentum, driven by high digital literacy, favorable regulations, and rapid adoption of technology. Since most consumers (~95%) are digitally savvy, a tendency to prefer mobile...

Estonia’s Rise as Europe’s Fintech Powerhouse

01/12/2024by EOS Intelligence

Estonia, a small Baltic country with a population of 1.4 million, is in the news for all the right reasons: its burgeoning fintech sector. With a market size of €15.2 billion...

Open Banking Sparking a Wave of Innovation in Financial Services

21/11/2024by EOS Intelligence

The adoption of open banking is leading to innovation across financial solutions such as account-to-account payments (A2A), personal finance management (PFM) apps, embedded finance, and banking-as-a-service (BaaS) by enabling real-time...

New Directions in Alzheimer’s Diagnostics: Will Blood Tests Replace CSF and PET?

30/09/2024by EOS Intelligence

Around three-fourths of dementia cases continue to remain undiagnosed even though the incidence of Alzheimer’s disease (AD) is rapidly growing across the globe. AD affects about 60-80% of dementia patients...

Phase 3 Drug Candidates – A Ray of Hope in Alzheimer’s Disease Bleak Treatment Landscape?

26/09/2024by EOS Intelligence

Many biopharmaceutical companies, such as AriBio, Annovis Bio, Athira Pharma, Cassava Sciences, and Alzheon, specializing in treating neurodegenerative diseases, are developing drugs for Alzheimer’s disease (AD) that are currently in...

What’s Fueling Asia’s Drive to Develop Wholesale CBDCs?

22/08/2024by EOS Intelligence

The emergence of Central Bank Digital Currencies (CBDCs) has become a central focus in the global financial space, as it offers the potential for revolutionary shifts in how the world...

Who We Are

Connect With Us

Work With EOS